This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Teladoc (TDOC) to Buy Best Doctors, Stock Hits New High
by Zacks Equity Research
Teladoc Inc. (TDOC) has inked a definitive agreement to acquire Best Doctors, a leader in medical consultation.
Luminex (LMNX) Scores a Strong Buy Right Now: Here's How
by Zacks Equity Research
With solid growth prospects, Luminex Corporation (LMNX) carries a Zacks Rank #1 (Strong Buy) which is an attractive pick at present.
ResMed (RMD) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of ResMed Inc. (RMD) scaled a new 52-week high of $79.22 on Jun 19, eventually closing a bit lower at $78.91.
PRA Health (PRAH) Shares Rally on Partnership with Jumo
by Zacks Equity Research
Shares of PRA Health (PRAH) rallied 2.3% to close at $75.50, following PRA Health's recently announced partnership with Jumo, a global provider of educational health care information.
Neogen Offers NeoSeek Genomic Services to Ensure Food Safety
by Zacks Equity Research
Headquartered in Lansing, MI, Neogen Corporation (NEOG) recently announced the availability of next generation sequencing services for the food industry.
PAREXEL to Launch Connected Journey Data-Driven Services
by Zacks Equity Research
PAREXEL International Corporation (PRXL) recently announced the launch of its proprietary data-driven services, Connected Journey.
Medtronic Posts Positive Result on Reactive ATP, Grows in AF
by Zacks Equity Research
Medtronic's (MDT) Reactive ATP therapy slows the progression of AF in patients who are being implanted with cardiac devices.
DENTSPLY (XRAY) Renews Partnership with Pacific Dental
by Zacks Equity Research
DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced that it has renewed its strategic partnership with Pacific Dental Services, LLC.
Universal Health Grows on Acquisitions, Rising Debt a Drag
by Zacks Equity Research
Universal Health Services, Inc.'s (UHS)s inorganic strategies substantially make it well positioned for long-term growth.
Inogen (INGN) Scores a Strong Buy Right Now: Here's How
by Zacks Equity Research
Goleta, CA-based Inogen Inc. (INGN), a provider of portable oxygen concentrators (POC), is on a healthy growth trajectory of late.
Why Does Intuitive Surgical Score as a Strong Buy Right Now
by Zacks Equity Research
Over the last three months, Intuitive Surgical Inc. (ISRG) was trading consistently ahead of the S&P 500 Index.
Pacific Biosciences (PACB) Prices Offering of Common Stock
by Zacks Equity Research
Pacific Biosciences of California, Inc. (PACB) recently announced that it has priced its underwritten public offering of 15.4 million shares of its common stock.
DaVita (DVA) Rolls Out Alliance Site Network for CKD Trial
by Zacks Equity Research
DaVita Inc (DVA), through its subsidiary DaVita Clinical Research (DCR), recently announced the expansion of its research services to include Alliance Site Network.
Varian Showcases Halcyon System at DEGRO Meet, Stock Up
by Zacks Equity Research
Shares of Varian Medical Systems Inc. (VAR) rallied almost 1% after the company showcased a new Halcyon radiotherapy treatment system at the 2017 DEGRO meeting, the German radiation oncology society, in Berlin.
TransEnterix Sells Surgery System to Japanese University
by Zacks Equity Research
TransEnterix, Inc. (TRXC), a global medical technology company, recently announced that it has sold a Senhance Robotic Surgery System to a Japanese customer.
Here's Why Phibro Animal Health Is Worth Buying Right Now
by Zacks Equity Research
Phibro Animal Health Corporation (PAHC), has rallied 24.2% over the past three months, ahead of the S&P 500's mere 2.6% gain.
LabCorp to Grow in Precision Med with Cancer Diagnostics Lab
by Zacks Equity Research
LabCorp's (LH) Covance drug development business has recently opened a companion diagnostics laboratory in Morrisville, North Carolina to expand capabilities in precision medicine field.
Abbott Laboratories Up on EPD & Buyouts, Pediatric Weak
by Zacks Equity Research
On Jun 14, we issued an updated research report on Illinois-based Abbott Laboratories (ABT). It is a leading distributor of health care products and services across the globe.
Baxter-Dorizoe Ink Deal to Expand Generic Injectables Line
by Zacks Equity Research
Deerfield, IL-based Baxter International Inc. (BAX), a global medical technology company, recently signed an agreement with India-based Dorizoe Lifesciences for expansion of its generic injectables pipeline.
Henry Schein Grows on Strategic Buyouts, Competition Rife
by Zacks Equity Research
On Jun 15, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).
Haemonetics Rides on Solid Plasma, Slows Blood Center Growth
by Zacks Equity Research
On Jun 13, we issued an updated research report on Haemonetics Corporation (HAE).
Civitas Solutions (CIVI) Extends ADH Platform to New Jersey
by Zacks Equity Research
Civitas Solutions, Inc. (CIVI) recently announced that it has expanded its platform of Adult Day Health services to the state of New Jersey.
Medtronic Resource Centre Opens for Diabetic People in Canada
by Zacks Equity Research
Medtronic plc (MDT) announced that its subsidiary has opened its first Canadian Medtronic Resource Centre to serve diabetic patients in Surrey BC and nearby.
CONMED (CNMD) Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Shares of Utica, NY-based leading medical technology player, CONMED Corporation (CNMD) rallied to a new 52-week high of $52.79 on Jun 13, closing a little lower at $52.49.
Hill-Rom Rides High on Solid Prospects, Asia-Pacific a Drag
by Zacks Equity Research
On Jun 11, we issued an updated research report on Batesville, IN-based Hill-Rom Holdings, Inc. (HRC) -- a leading global medical device company.